NextPlat Q1 revenue down to $14.5M, net loss improves; tariffs pause China product launch

NextPlat Corp

2025-Q1 EPS reported -$0.05 revenue$14,525,000

Revenue of $14.5M, down 17% YoY from $17.5M; Healthcare segment declined due to 340B program changes.
Gross margin fell to 23.8% from 27.8%; operating expenses down 26.2% to $4.9M.
Net loss attributable to common shareholders narrowed 9% to $1.3M ($0.05/share) from $1.5M ($0.08/share).
e-Commerce airtime recurring revenue rose 51% to record level; secured new connectivity contracts.
Florida Sunshine vitamin launch in China paused due to tariffs; exploring alternative markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.